American Vanguard Co. (NYSE:AVD) insider Peter Porpiglia sold 4,290 shares of the business’s stock in a transaction that occurred on Wednesday, May 12th. The stock was sold at an average price of $19.31, for a total transaction of $82,839.90. Following the sale, the insider now owns 38,594 shares of the company’s stock, valued at approximately $745,250.14. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
AVD stock opened at $17.71 on Friday. The firm has a fifty day simple moving average of $19.39. American Vanguard Co. has a 12 month low of $11.85 and a 12 month high of $22.49. The stock has a market cap of $545.96 million, a P/E ratio of 30.02 and a beta of 0.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.16 and a current ratio of 2.19.
American Vanguard (NYSE:AVD) last released its quarterly earnings results on Wednesday, May 5th. The basic materials company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.01 by $0.09. The firm had revenue of $116.16 million during the quarter, compared to the consensus estimate of $108.40 million. American Vanguard had a net margin of 3.72% and a return on equity of 5.06%. As a group, research analysts anticipate that American Vanguard Co. will post 0.71 EPS for the current year.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Van ECK Associates Corp acquired a new stake in American Vanguard in the 1st quarter valued at about $32,000. Lazard Asset Management LLC acquired a new stake in shares of American Vanguard during the 4th quarter worth about $55,000. Citigroup Inc. boosted its stake in shares of American Vanguard by 282.7% during the 4th quarter. Citigroup Inc. now owns 6,920 shares of the basic materials company’s stock worth $107,000 after purchasing an additional 5,112 shares during the last quarter. Strs Ohio acquired a new stake in shares of American Vanguard during the 1st quarter worth about $126,000. Finally, Trexquant Investment LP acquired a new stake in shares of American Vanguard during the 1st quarter worth about $200,000. 77.70% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have recently weighed in on AVD. TheStreet upgraded shares of American Vanguard from a “c” rating to a “b-” rating in a research report on Wednesday, February 24th. Loop Capital boosted their price objective on shares of American Vanguard from $19.00 to $23.00 and gave the stock a “buy” rating in a research report on Tuesday, May 4th. Finally, Roth Capital boosted their price objective on shares of American Vanguard from $16.00 to $24.00 and gave the stock a “buy” rating in a research report on Tuesday, May 4th.
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Further Reading: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.